Drug Efficacy Analysis
David and Carolina dive into the nuances of FDA data concerning dementia treatments, emphasizing the minimal changes observed in the mini mental status examination. They highlight the importance of clinical endpoints, such as the clinical dementia rating, and discuss how high doses of a drug can sometimes lead to negative outcomes. The conversation sheds light on the complexities of interpreting study results and the significance of confidence intervals in clinical research.In this clip
From this podcast
Psychiatry & Psychotherapy Podcast
Alzheimer’s Dementia
Related Questions